Showing results (811-820 of 6,510) with videos related to

Sort By:
Pageof 651
Experimental Hematology|October 1, 1991
Uteroferrin: a progesterone-induced hematopoietic growth factor of uterine originF W Bazer, D Worthington-White, M F Fliss, et al.
Experimental Hematology|October 1, 1991
Short- and long-term repopulation of lethally irradiated mice by bone marrow stem cells enriched on the basis of light scatter and Hoechst 33342 fluorescenceS Neben, W J Redfearn, M Parra, et al.
Experimental Hematology|October 1, 1991
Characterization of FDCP-2, a cloned hemopoietic progenitor cell deficient in homing proteinC L Hardy, E Omoto, M Tavassoli
Experimental Hematology|October 1, 1991
Growth of primary human acute leukemia in severe combined immunodeficient miceC De Lord, R Clutterbuck, J Titley, et al.
Experimental Hematology|September 4, 2007
A constitutively active SPTBN1-FLT3 fusion in atypical chronic myeloid leukemia is sensitive to tyrosine kinase inhibitors and immunotherapyFrancis H Grand, Sameena Iqbal, Lingyan Zhang, et al.
Experimental Hematology|September 4, 2007
Factors affecting human T cell engraftment, trafficking, and associated xenogeneic graft-vs-host disease in NOD/SCID beta2mnull miceBruno Nervi, Michael P Rettig, Julie K Ritchey, et al.
Experimental Hematology|November 28, 2016
Lenalidomide enhances the function of dendritic cells generated from patients with multiple myelomaManh-Cuong Vo, Truc Anh-NguyenThi, Hyun-Ju Lee, et al.
Experimental Hematology|October 1, 1989
Evidence that precursor cells of monocytes and B-lymphocytes are closely relatedA K Wong, C M Bunce, J M Lord, et al.
Experimental Hematology|August 12, 2020
Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 studyFatemeh Saberi Hosnijeh, Lina van der Straten, Arnon P Kater, et al.
Experimental Hematology|August 18, 2020
Over 60 Years of Experimental Hematology (without a License)Harvey F Lodish
Pageof 651